Emerald Advisers Inc. PA Buys 566,608 Shares of Nutrisystem Inc. (NTRI)
Emerald Advisers Inc. PA increased its stake in shares of Nutrisystem Inc. (NASDAQ:NTRI) by 150.8% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 942,255 shares of the company’s stock after buying an additional 566,608 shares during the period. Nutrisystem makes up about 1.2% of Emerald Advisers Inc. PA’s portfolio, making the stock its 15th largest position. Emerald Advisers Inc. PA owned approximately 3.23% of Nutrisystem worth $23,896,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Envestnet Asset Management Inc. boosted its stake in shares of Nutrisystem by 219.8% in the first quarter. Envestnet Asset Management Inc. now owns 5,798 shares of the company’s stock valued at $121,000 after buying an additional 3,985 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Nutrisystem by 99.7% in the second quarter. BNP Paribas Arbitrage SA now owns 9,586 shares of the company’s stock valued at $243,000 after buying an additional 4,787 shares during the last quarter. Arizona State Retirement System boosted its stake in shares of Nutrisystem by 0.7% in the first quarter. Arizona State Retirement System now owns 15,017 shares of the company’s stock valued at $313,000 after buying an additional 100 shares during the last quarter. Palo Capital Inc. bought a new stake in shares of Nutrisystem during the second quarter valued at $370,000. Finally, Capstone Asset Management Co. boosted its stake in shares of Nutrisystem by 20.0% in the second quarter. Capstone Asset Management Co. now owns 16,246 shares of the company’s stock valued at $412,000 after buying an additional 2,710 shares during the last quarter. 93.77% of the stock is owned by institutional investors.
Shares of Nutrisystem Inc. (NASDAQ:NTRI) traded up 0.47% on Tuesday, reaching $29.63. The company’s stock had a trading volume of 87,428 shares. The company’s 50 day moving average price is $28.88 and its 200 day moving average price is $25.76. The company has a market cap of $867.39 million, a P/E ratio of 29.31 and a beta of 0.76. Nutrisystem Inc. has a 12-month low of $17.25 and a 12-month high of $30.45.
Nutrisystem (NASDAQ:NTRI) last issued its quarterly earnings results on Wednesday, July 27th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.04. Nutrisystem had a return on equity of 45.65% and a net margin of 5.87%. The firm earned $149.80 million during the quarter, compared to analyst estimates of $148.77 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue was up 15.0% compared to the same quarter last year. Analysts forecast that Nutrisystem Inc. will post $1.11 EPS for the current fiscal year.
NTRI has been the subject of several recent research reports. B. Riley reissued a “buy” rating and issued a $41.00 price target on shares of Nutrisystem in a research note on Monday, September 12th. Zacks Investment Research raised Nutrisystem from a “hold” rating to a “buy” rating and set a $33.00 target price for the company in a research note on Saturday, July 30th. Citigroup Inc. raised their target price on Nutrisystem from $31.00 to $36.00 and gave the stock a “neutral” rating in a research note on Tuesday, September 13th. Finally, Barrington Research reaffirmed an “outperform” rating on shares of Nutrisystem in a research note on Sunday, July 31st. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $32.67.
In other news, CMO Keira Krausz sold 20,000 shares of the business’s stock in a transaction dated Friday, July 15th. The stock was sold at an average price of $26.26, for a total value of $525,200.00. Following the completion of the sale, the chief marketing officer now owns 92,362 shares of the company’s stock, valued at approximately $2,425,426.12. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Brian Tierney sold 7,000 shares of the business’s stock in a transaction dated Tuesday, August 16th. The shares were sold at an average price of $29.25, for a total value of $204,750.00. Following the completion of the sale, the director now directly owns 40,620 shares of the company’s stock, valued at approximately $1,188,135. The disclosure for this sale can be found here. Company insiders own 2.90% of the company’s stock.
Nutrisystem Company Profile
Nutrisystem, Inc (Nutrisystem) is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.
Receive News & Stock Ratings for Nutrisystem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem Inc. and related stocks with our FREE daily email newsletter.